Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | PCLX-001 |
Trade Name | |
Synonyms | PCLX 001|PCLX001|Zelenirstat |
Drug Descriptions |
PCLX-001 inhibits the N-myristoyl-transferases NMT1 and NMT2, potentially resulting in inhibition of early B-cell receptor signaling and degradation of pERK, c-Myc, NFkappaB and CREB, which may lead to tumor cell apoptosis, decreased cell proliferation, and inhibition of tumor growth (PMID: 33093447). |
DrugClasses | |
CAS Registry Number | 1215011-08-7 |
NCIT ID | C180576 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
PCLX-001 | PCLX-001 | 0 | 1 |